Streetbeat News

Stock Prices

PACS

PACS Group's stock is trading lower following the announcement of a public offering of 13.88 million shares of its common stock.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:11 pm

HLX

PXJ

SHEL

SLB

Helix Energy Solutions Group, Inc. (NYSE:HLX) has secured a multi-year agreement with Shell Offshore Inc, a unit of Shell PLC (NYSE:SHEL), to provide well intervention services in the U.S. Gulf of Mexico starting in 2025. The contract reflects improving market conditions and increased demand for Helix's services. Helix will use its Q5000 vessel and other equipment, in collaboration with Schlumberger (NYSE:SLB), to deliver integrated operations. HLX shares have gained over 4.9% in the past month.

Portfolio Pulse from Nabaparna Bhattacharya

September 04, 2024 | 3:08 pm

MRNA

Moderna has reported positive results for its mpox vaccine, which comes at a crucial time as mpox outbreaks are spreading in Africa. This development could enhance Moderna's vaccine portfolio and potentially boost its stock performance.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:05 pm

SMCI

Super Micro Computer's stock is trading lower following a downgrade by Barclays from Overweight to Equal-Weight, with a reduced price target from $693 to $438.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:04 pm

BYU

BAIYU Holdings shares have been halted to the downside, with the stock experiencing a significant drop of 69.60%.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:01 pm

FAF

Analysts have mixed views on First American Financial (NYSE:FAF) with recent ratings showing a slight bullish trend. The average 12-month price target has increased to $66.0. Despite some financial challenges, analysts have adjusted their ratings and price targets, reflecting their varied outlooks.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 3:01 pm

HES

In the past three months, 7 analysts have provided ratings for Hess (NYSE:HES), ranging from bullish to bearish. The average 12-month price target is $168.57, a decrease from the previous $174.29. Analysts have adjusted their ratings and price targets in response to market dynamics and company performance. Hess, an independent oil and gas producer, has shown strong financial performance with significant revenue growth and profitability, but has a higher debt-to-equity ratio than industry averages.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 3:00 pm

CRM

Salesforce (NYSE:CRM) is potentially undervalued compared to its peers in the software industry, with lower PE, PB, and PS ratios. However, its ROE is below the industry average, indicating lower profitability. Despite strong EBITDA and gross profit, its revenue growth lags behind peers.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 3:00 pm

RXRX

Analysts have provided mixed evaluations for Recursion Pharmaceuticals (NASDAQ:RXRX), with a recent decline in average price targets. The company's financial performance shows strong revenue growth but challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 3:00 pm